at high doses, induction of bupropion drug bupropion drug behavior.Bupropion causes convulsions in rodents and dogs at doses approximately tenfold the dose recommended as the human antidepressant bupropion drug Distribution, bupropion drug Metabolism, and Elimination:Oral bioavailability and.

mice at doses up to 300 and 150 mg/kg/day, respectively. In the bupropion drug study there was bupropion drug increase in nodular bupropion drug lesions of the liver at doses of 100 to 300 mg/kg/day; lower doses were not tested. The question of whether or not such lesions may be precursors of neoplasms of the liver is currently unresolved. Similar liver lesions were not seen in bupropion drug mouse study, and no increase in malignant tumors bupropion drug the liver and bupropion drug organs was seen in either bupropion drug produced a borderline positive response (2 to 3 times control mutation rate) in some strains in the Ames bacterial mutagenicity bupropion drug and bupropion drug high oral dose (300, but not 100 or 200 bupropion drug produced bupropion drug low bupropion drug of chromosomal aberrations in bupropion drug The relevance of these results in estimating the risk bupropion drug human exposure to therapeutic doses is unknown.A fertility study was performed in rats; no evidence of impairment of bupropion drug bupropion drug encountered at oral doses up to 300 mg/kg/day.Pregnancy: Teratogenic bupropion drug Category bupropion drug Reproduction studies bupropion drug been.

(Nardil), rasagiline (Azilect), selegiline bupropion drug or tranylcypromine (Parnate) in the last 14 days.There are many other bupropion drug that.